The UCB-Ehrlich Award for Excellence in Medicinal Chemistry
The “UCB-Ehrlich Award for Excellence in Medicinal Chemistry” was established to acknowledge and recognize outstanding research in the field of Medicinal Chemistry in its broadest sense. The Award is given biennially, without restrictions regarding nationality, and consists of diploma, € 7.500 and an invitation to present a lecture at an EFMC-ISMC symposium.
Previous recipients were: Dr. B. Riedl in 2006, Prof. J. Wengel in 2004 and Dr. J. Zimmermann in 2002.
Dr Bernd Riedl, Director at BayerHealthCare AG, Leverkusen, Germany
Winner of the 2006 UCB Award for Excellence in Medicinal Chemistry
Dr. Riedl receives this award for his outstanding scientific work leading to the discovery of the raf-kinase inhibitor Sorafenib (Bay-43-9006, Nexavar), the first example of the discovery of a new medicine which combines classical rationale drug discovery approach with the use of new technologies.
The UCB Award for Excellence in Medicinal Chemistry 2004 for Prof. Jesper Wengel
The UCB Award for Excellence in Medicinal Chemistry 2002 for Dr. Jürg Zimmermann, NOVARTIS, Basel, Switzerland
The first "UCB Award for Excellence in Medicinal Chemistry" has been given to Dr. Jürg Zimmermann of Novartis, Switzerland. Dr. Zimmermann received the Award for his fundamental contributions in medicinal chemistry to the discovery and development of Imatinib (Glivec/Gleevec, STI 571), a Protein Kinase Inhibitor and novel treatment for Chronic Myeloid Leukemia. Imatinib is considered as one of the revolutions in the therapeutic treatment of cancer, and could become the therapy of choice. The Jury noted the Excellence in Medicinal Chemistry, combining chemical knowledge with a profound expertise in molecular pharmacology together with rigorous molecular design techniques, which formed the basis of this work.
Follow us on Twitter
Follow us on LinkedIn